Insider Trades of KUFE DONALD W Information

Click on the column header to resort 'ascending (^) or descending (v).

Individual Insider Trades

Company Relation Last Date Type Tran OwnerType Shares Traded Last Price Shares Held
SYNTA PHARMACEUTICALS CORP Director 07/01/2012 Form 4 Acquisition (Non Open Market) direct 7,312 0 7,312
SYNTA PHARMACEUTICALS CORP Director 07/25/2012 Form 4 Acquisition (Non Open Market) direct 4,622 6.49 11,934
SYNTA PHARMACEUTICALS CORP Director 12/12/2012 Form 4 Acquisition (Non Open Market) direct 5,814 8.6 17,748

Latest News Headlines

Google CEO Defends Tax Affairs    1:15AM ET  - Dow Jones Business News

Goldman Sachs Chief Confident Euro Will Survive   12:55AM ET  - Dow Jones Business News

UPDATE: Hon Hai Confirms Death of Two Employees in Zhengzhou, China   12:53AM ET  - Dow Jones Business News

Microsoft to Unveil New Xbox    9:55PM ET  - Dow Jones Business News

Goldman Sachs to Invest in Japan Green Energy    9:55PM ET  - Dow Jones Business News

View All
Create your free portfolio